Premium
Aligos Therapeutics Inc (ALGS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment ... Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity. The company also develops pevifoscorvir sodium, a capsid assembly modulator, which is in Phase 2 B clinical trial; and ALG-097558, a small molecule ritonavir-free pan-coronavirus protease inhibitor which has completed a Phase 1 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Emory University; and Katholieke Universiteit Leuven. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.09 | -18.3501683502 | 5.94 | 5.94 | 4.8098 | 137734 | 5.36022459 | CS |
| 4 | -1.26 | -20.6219312602 | 6.11 | 6.875 | 4.8098 | 144718 | 5.83294787 | CS |
| 12 | -2.64 | -35.2469959947 | 7.49 | 8.97 | 4.8098 | 218767 | 6.97017714 | CS |
| 26 | -5.27 | -52.0750988142 | 10.12 | 13.6892 | 4.8098 | 135062 | 7.44443195 | CS |
| 52 | -1.4 | -22.4 | 6.25 | 13.6892 | 4.8098 | 111356 | 7.97764885 | CS |
| 156 | 3.65 | 304.166666667 | 1.2 | 46.8 | 0.3482 | 213673 | 7.96512132 | CS |
| 260 | -24.3 | -83.3619210978 | 29.15 | 46.8 | 0.3482 | 238984 | 6.85780641 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
